Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $46.30. The company's market cap stands at 94.16B, with a P/E ratio of 15.62 and a dividend yield of 5.4%.
As of 2025-11-23, Bristol-Myers Squibb(BMY) stock has fluctuated between $45.52 and $46.99. The current price stands at $46.30, placing the stock +1.7% above today's low and -1.5% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 14.18M, compared to an average daily volume of 14.08M.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.
BMY News
In November 2025, Texas Attorney General Ken Paxton filed a lawsuit against Bristol-Myers Squibb and Sanofi, alleging the companies failed to disclose that thei...
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Invest...
Curious if Bristol-Myers Squibb is finally a bargain, or whether there is still further to fall? Let’s dig into its value to see if now is the time to pay atten...
Analyst ratings
70%
of 30 ratingsMore BMY News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Bristol-Myers Squibb (BMY) shares have had a mixed performance over the past month, gaining around 7%. Investors are closely watching revenue trends and profit...